ClinicalTrials.gg
Drug

Bixalomer clinical trials

Also written ASP1585 and AMG223.

studies test it
15
open now
0
in phase 3
5
first study started
2006

How each study uses bixalomer is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bixalomer
4

Brand

Kiklin
1

Development codes

ASP1585
12
AMG223
7
ILY101
4
LY101
2

Studies by the year they started

15 studies that test it; most in 2010 (5)

Studies that test bixalomer, by start year
YearStudies
20061
20071
20083
20092
20105
20121
20131
20141

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
4
Phase 3
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 15 · Other 0

Astellas Pharma Inc (12) · Amgen (1) · Amgen Research (Munich) GmbH (1) · Ilypsa (1)

Often tested with

Tested in the same studies.

Valsartan (1) · Enalapril (1) · Atorvastatin (1)

Studies

Open first, then newest update. How each study uses bixalomer is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 15

Codes

What other systems call bixalomer · ClinicalTrials.gg INT000037

  • MeSH (NLM) C000589735bixalomerOne source NLM
  • UNII (FDA) 3160WY51LVBIXALOMERConfirmed FDA, NLM
  • NCI Thesaurus C166622BixalomerOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.